Darunavir (TMC114): a new HIV-1 protease inhibitor (Q36909289)

17 August 2017

1 reference

title

Darunavir (TMC114): a new HIV-1 protease inhibitor (English)

1 reference

17 August 2017

1 reference

Jean-Michel Molina

1

1 reference

PubMed ID

17696796

17 August 2017

Andrew Hill

series ordinal

2

1 reference

PubMed ID

17696796

17 August 2017

language of work or name

English

0 references

publication date

1 August 2007

1 reference

Expert Opinion on Pharmacotherapy

17 August 2017

1 reference

17 August 2017

8

1 reference

17 August 2017

12

1 reference

17 August 2017

1951-1964

1 reference

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

17 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1951

Decline in the AIDS and death rates in the EuroSIDA study: an observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1951

The changing face of the HIV epidemic in western Europe: what are the implications for public health policies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1951

Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1951

Week 24 efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1951

Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1951

High resolution crystal structures of HIV-1 protease with a potent non-peptide inhibitor (UIC-94017) active against multi-drug-resistant clinical strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1951

Novel bis-tetrahydrofuranylurethane-containing nonpeptidic protease inhibitor (PI) UIC-94017 (TMC114) with potent activity against multi-PI-resistant human immunodeficiency virus in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1951

TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1951

The effect of different meal types on the pharmacokinetics of darunavir (TMC114)/ritonavir in HIV-negative healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1951

The binding of HIV-1 protease inhibitors to human serum proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1951

Pharmacokinetic interaction between darunavir boosted with ritonavir and omeprazole or ranitidine in human immunodeficiency virus-negative healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1951

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1951

Epidemiology of antiretroviral drug resistance in drug-naïve persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1951

Body fat and other metabolic effects of atazanavir and efavirenz, each administered in combination with zidovudine plus lamivudine, in antiretroviral-naive HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1951

Treatment for adult HIV infection: 2006 recommendations of the International AIDS Society-USA panel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.8.12.1951

10.1517/14656566.8.12.1951

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference

PubMed ID

17696796